Who makes clomiphene citrate-uFSH arm?

clomiphene citrate-uFSH arm is developed by Mansoura Integrated Fertility Center.

What development phase is clomiphene citrate-uFSH arm in?

clomiphene citrate-uFSH arm is in Phase 1.

Last reviewed 2026-05-15 · How we verify

clomiphene citrate-uFSH arm

Mansoura Integrated Fertility Center · Phase 1 active Small molecule

At a glance

Generic name	clomiphene citrate-uFSH arm
Sponsor	Mansoura Integrated Fertility Center
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Clomiphene Citrate Plus uFSH Versus Aromatase Inhibitor Plus uFSH in Clomiphene Resistant Infertile PCOS Women (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

clomiphene citrate-uFSH arm CI brief — competitive landscape report
clomiphene citrate-uFSH arm updates RSS · CI watch RSS
Mansoura Integrated Fertility Center portfolio CI